Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

被引：231
作者：
Miller, Stephen D. [1 ]
Turley, Danielle M. [1 ]
Podojil, Joseph R. [1 ]
机构：
[1] Northwestern Univ, Immunobiol Ctr, Dept Microbiol Immunol & Interdepartmental, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 09期
关键词：
D O I：
10.1038/nri2153
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The development of safe and effective antigen-specific therapies is needed to treat patients with autoimmune diseases. These therapies must allow for the specific tolerization of self-reactive immune cells without altering host immunity to infectious insults. Experimental models and clinical trials for the treatment of autoimmune disease have identified putative mechanisms by which antigen-specific therapies induce tolerance. Although advances have been made in the development of efficient antigen-specific therapies, translating these therapies from bench to bedside has remained difficult. Here, we discuss the recent advances in our understanding of antigen-specific therapies for the treatment of autoimmune diseases.
引用
收藏
页码：665 / 677
页数：13
相关论文
共 122 条
  • [1] Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking
    Aharoni, R
    Teitelbaum, D
    Arnon, R
    Sela, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) : 634 - 639
  • [2] Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B(9-23) epitope
    Alleva, DG
    Maki, RA
    Putnam, AL
    Robinson, JM
    Kipnes, MS
    Dandona, P
    Marks, JB
    Simmons, DL
    Greenbaum, CJ
    Jimenez, RG
    Conlon, PJ
    Gottlieb, PA
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (01) : 59 - 69
  • [3] GRAIL:: An E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells
    Anandasabapathy, N
    Ford, GS
    Bloom, D
    Holness, C
    Paragas, V
    Seroogy, C
    Skrenta, H
    Hollenhorst, M
    Fathman, CG
    Soares, L
    [J]. IMMUNITY, 2003, 18 (04) : 535 - 547
  • [4] Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA
    Bai, XF
    Shi, FD
    Xiao, BG
    Li, HL
    vanderMeide, PH
    Link, H
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) : 65 - 75
  • [5] Bai XF, 1998, CLIN EXP IMMUNOL, V111, P205
  • [6] CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE
    Bailey, Samantha L.
    Schreiner, Bettina
    McMahon, Eileen J.
    Miller, Stephen D.
    [J]. NATURE IMMUNOLOGY, 2007, 8 (02) : 172 - 180
  • [7] Barnett ML, 1998, ARTHRITIS RHEUM, V41, P290, DOI 10.1002/1529-0131(199802)41:2<290::AID-ART13>3.3.CO
  • [8] 2-I
  • [9] TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
    Belghith, M
    Bluestone, JA
    Barriot, S
    Mégret, J
    Bach, JF
    Chatenoud, L
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1202 - 1208
  • [10] Benson JM, 1999, J IMMUNOL, V162, P6247
12345678910